Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.
Explore this paper's citation graph
Summary
Mice given injections of living methylcholanthrene-induced fibrosarcoma cells after the complete surgical removal of a growing, sensitizing tumor implant showed a strong immune resistance to the growth of the injected cells, although large doses of either tumor depressed host resistance, probably in part because of nonspecific toxic depression.
- Type
- article
- Published
- 1971-11-01
- Cited by
- 86
- References
- 38
- OpenAlex
- https://openalex.org/W1560196793
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:14355987
Keywords
Fibrosarcoma, Immunity, Immune system, Neoplasm, Methylcholanthrene
References
- ANTIBODY-MEDIATED SUPPRESSION OF THE IMMUNE RESPONSE IN VITRO
- DELAYED HYPERSENSITIVITY
- Desensitization in vitro--the specific inhibition, by antigen, of the passive transfer of delayed hypersensitivity by peritoneal exudate cells.
- Arbeiten aus dem Königlichen Institut für Experimentelle Therapie zu Frankfurt a.M.
- Antigenic differences among virus-induced mouse mammary tumors arising spontaneously in the same C3H-Crgl host.
- IMMUNITY TO SPONTANEOUS AND METHYLCHOLANTHRENE-INDUCED TUMORS IN INBRED MICE.
- Nonvirus-associated antigens in virus-induced mouse mammary tumors.
- Treatment of artificial metastases of methylcholanthrene-induced rat sarcomas by autoimmunization of the autochthonous hosts.
- Studies on immunization. 1. The effect of route of injection of bovine serum albumin in Freund adjuvant on production of circulating antibody and delayed hypersensitivity.
- Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. I. Quantitative cell transplants into mammary-tumor-agent-positive and -free mice.
- Immune status of the primary host toward its own methylcholanthrene-induced sarcomas.
- Evolution of cell-mediated immunity in mice bearing an antigenic tumor. Influence of tumor growth and surgical removal.
- IMMUNE RESPONSES IN VITRO
- IMMUNOLOGICAL DETERMINANTS OF ONCOGENESIS IN HAMSTERS INFECTED WITH SV40 VIRUS.
- On Concomitant Immunity in Tumour-bearing Hamsters
- Immunologic status of host and response of a methylcholanthrene‐induced sarcoma to local x‐irradiation
- ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS *
- A mechanical technique for obtaining high yields of viable, dispersed tumor cells.
- Tuberculin-induced mitosis in peripheral blood leucocytes.
- Co-existence of allogeneic tumour growth and homograft immunity in man.
Cited by
- Humoral factors abrogating cell-mediated immunity in the tumor-bearing host.
- Late appearance of resistance to tumor rechallenge following cryosurgery. A study in an experimental mammary tumor of the rat.
- A note on concomitant immunity in host-parasite relationships: a successfully transplanted concept from tumor immunology.
- Concomitant tumor immunity and the resistance to a second tumor challenge.
- Down-regulation of the antitumor immune response.
- Mathematical Models of Tumor Growth and Therapy
- Immunological aspects of chemical carcinogenesis.
- BCG in tumor immunotherapy.
- Induction of tumor-immune responses and their interaction with the developing tumor.
- Tumour rejection antigens associated with carcinogen-induced tumours
- T-lymphocytes and macrophages in primary murine fibrosarcomas at different stages in their progression.
- Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
- Adoptive immunotherapy of a Gross virus producing lymphoma and a methylcholanthrene-induced fibrosarcoma in tolerant rats.
- In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice.
- Delayed cutaneous hypersensitivity to oxazolone in mice with tumors.
- Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
- Immune functions characteristic of SJL/J mice and their association with age and spontaneous reticulum cell sarcoma.
- Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
- Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
- Serum therapy for radiation-induced impairment of immune resistance to metastasis.
Related papers
- Preoperative versus Postoperative Concomitant Chemoradiation in Locally Advanced Rectal Cancer: First Greek Comparative Retrospective Trial With 153 Patients
- Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy.
- Concomitant Cholecystectomy During Initial Bariatric Surgery Does Not Increase Risk of Postoperative Complications or Bile Duct Injuries
- OUTCOMES OF CONCOMITANT ACUTE KIDNEY INJURY AND HOSPITAL ACQUIRED ANEMIA IN PATIENTS WITH MYOCARDIAL INFARCTION: THE TRIUMPH STUDY
- OUTCOMES AND CHARACTERISTICS OF PATIENTS UNDERGOING PERICARDIOCENTESIS WITH CONCOMITANT BLOOD TRANSFUSION
- Pamidronate (P) dose-intensified administration and concomitant radiotherapy (RT) in patients (PTS) with symptomatic bone metastases (BM): Preliminary results of a pilot study
- Risk of Unplanned Hospitalization During Treatment With Concomitant Chemoradiation Therapy
- Predictors Associated with Severe Acute Esophagitis in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Concomitant Boost Chemoradiation
- Preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer: Preliminary analysis of surgical and pathologic outcones